Skip to main content
Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Gaudium IVF and Women Health Ltd

| Quarterly Financial Results Q3 FY 2025–26

Report Source

18th Mar 26

Summary : Gaudium IVF reported strong financial results, completed a successful IPO, and is navigating new labor regulations.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Cost of Rendering Services
  2. Purchase of Drugs and Medical Consumables
  3. Changes in Inventories of Medical Consumable and Drugs
  4. Employee benefits expense
  5. Finance costs
  6. Depreciation and amortisation expenses
  7. Other expenses
  8. Revenue from operations
  9. Other income
  10. Paid-up equity share capital (3,069.72 Lakhs as of Dec 31, 2025).
  11. Other equity (Standalone: 1,473.62 Lakhs, Consolidated: 1,560.02 Lakhs as of Mar 31, 2025).
  12. Both standalone and consolidated financial results are presented.
  13. Consolidated results include Gaudium International Private Limited and EKK Global Private Limited (till Aug 05, 2025).

Corporate Overview

  1. Registered office in New Delhi, India. Operations primarily in India.
  2. Evaluating potential impact of new Labour Codes on employee benefits.
  3. Reliance on medical professionals and healthcare infrastructure.
  4. Health Care Business, specifically IVF and Women Health services.
  5. Formal, compliant, and focused on reporting financial performance and regulatory adherence.
  6. Single operating segment: Health Care Business.

Risk Factors

  1. New Labour Codes implementation impact.
  2. Intense competition in healthcare sector.
  3. Regulatory changes in IVF industry.
  4. Dependence on key medical professionals.

Key Drivers

  1. Successful Initial Public Offering completed.
  2. Strong revenue growth in healthcare business.
  3. Increased net profit for the period.
  4. Shares listed on major exchanges.

Auditor’s Report

  1. Unmodified Review Report for standalone and consolidated financial results.
  2. Reliance on other auditors' reports for subsidiary financial results in consolidated statement.

Board Commentary

  1. New Labour Codes' impact on employee benefits, assessed as non-material.
  2. Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  3. Compliance with Companies Act, 2013.
  4. Completed Initial Public Offering (IPO) raising Rs. 16,500.098 Lakhs.

Corporate Governance

  1. Code on Prohibition of Insider Trading for Designated Persons.
  2. Audit Committee reviewed and recommended results.

Management Discussion & Analysis

Future Strategy

  1. Monitoring developments regarding New Labour Codes implementation.

Operational Focus Areas

  1. Ensuring compliance with SEBI regulations and Companies Act.
  2. Adhering to new Labour Codes for employee compensation.

Performance Drivers

  1. Increased revenue from operations.
  2. Growth in profit before tax and net profit.

Risk Control Measures

  1. Company already structures employee compensation per revised wage definition, expecting no material impact.

Critical Risks

  1. Potential impact of revised definition of 'Wages' under New Labour Codes.
Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Quarterly Report Analysis & Insights | Dhanarthi